| Date Filed | Type | Description |
| 10/10/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
| 08/18/2023 |
8-K
| Quarterly results |
| 08/10/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 08/08/2023 |
4
| Poulton Richard J. (CEO) has filed a Form 4 on Veradigm Inc.|
Txns:
| Granted 366,302 shares
@ $0
Disposed/sold 162,271 shares
@ $13.5, valued at
$2.2M
|
|
| 05/26/2023 |
4
| Hammond Lisa (SVP & Chief HR Officer) has filed a Form 4 on Veradigm Inc.|
Txns:
| Paid exercise price by delivering 1,519 shares
@ $11.89, valued at
$18.1k
|
|
| 05/19/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
| 05/11/2023 |
4
| Hammond Lisa (SVP & Chief HR Officer) has filed a Form 4 on Veradigm Inc.|
Txns:
| Paid exercise price by delivering 2,353 shares
@ $11.9, valued at
$28k
|
|
| 05/11/2023 |
4
| Poulton Richard J. (CEO) has filed a Form 4 on Veradigm Inc.|
Txns:
| Paid exercise price by delivering 13,205 shares
@ $11.9, valued at
$157.1k
|
|
| 05/11/2023 |
4
| Vakharia Tejal (SVP General Counsel) has filed a Form 4 on Veradigm Inc.|
Txns:
| Paid exercise price by delivering 3,169 shares
@ $11.9, valued at
$37.7k
|
|
| 05/11/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 05/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2023 |
4
| Langan Thomas (President and CCO) has filed a Form 4 on Veradigm Inc.|
Txns:
| Paid exercise price by delivering 9,354 shares
@ $12.53, valued at
$117.2k
Paid exercise price by delivering 1,893 shares
@ $12.15, valued at
$23k
|
|
| 05/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2023 |
4
| Vakharia Tejal (SVP General Counsel) has filed a Form 4 on Veradigm Inc.|
Txns:
| Paid exercise price by delivering 2,563 shares
@ $13.05, valued at
$33.4k
|
|
| 04/03/2023 |
4
| Langan Thomas (President and CCO) has filed a Form 4 on Veradigm Inc.|
Txns:
| Granted 10,304 shares
@ $0
Paid exercise price by delivering 3,307 shares
@ $13.05, valued at
$43.2k
Paid exercise price by delivering 8,955 shares
@ $13.05, valued at
$116.9k
Paid exercise price by delivering 2,544 shares
@ $13.05, valued at
$33.2k
|
|
| 04/03/2023 |
4
| Jones Leah (CFO) has filed a Form 4 on Veradigm Inc.|
Txns:
| Paid exercise price by delivering 4,473 shares
@ $13.05, valued at
$58.4k
Paid exercise price by delivering 3,736 shares
@ $13.05, valued at
$48.8k
|
|
| 04/03/2023 |
4
| Hammond Lisa (SVP & Chief HR Officer) has filed a Form 4 on Veradigm Inc.|
Txns:
| Paid exercise price by delivering 229 shares
@ $13.05, valued at
$3k
|
|
| 03/22/2023 |
8-K
| Results of Operations and Financial Condition, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard... |
| 03/06/2023 |
4
| Vakharia Tejal (SVP General Counsel) has filed a Form 4 on Veradigm Inc.|
Txns:
| Paid exercise price by delivering 3,515 shares
@ $14.36, valued at
$50.5k
|
|
| 03/06/2023 |
4
| Poulton Richard J. (CEO) has filed a Form 4 on Veradigm Inc.|
Txns:
| Paid exercise price by delivering 24,351 shares
@ $14.36, valued at
$349.7k
|
|
| 03/01/2023 |
3
| Ho Shih Yin (Director) has filed a Form 3 on Veradigm Inc. |
| 02/28/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 02/28/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 02/27/2023 |
3
| Rodriguez Susan (Director) has filed a Form 3 on Veradigm Inc. |
| 02/27/2023 |
4
| Poulton Richard J. (CEO) has filed a Form 4 on Veradigm Inc.|
Txns:
| Paid exercise price by delivering 11,991 shares
@ $16.85, valued at
$202k
Granted 366,302 shares
@ $0
Paid exercise price by delivering 159,474 shares
@ $16.85, valued at
$2.7M
|
|
| 02/22/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Veradigm Announces Two New Appointments to its Board Pharmaceutical executive Susan Rodriguez and digital health/pharma services entrepreneur Dr. Shih-Yin Ho join Board of Directors CHICAGO – FEBRUARY 22, 2023 – Susan Rodriguez and Shih-Yin Ho, MD have been named to the Board of Directors of Veradigm Inc. . With their combined experience in the pharmaceutical industry, digital health, and healthcare, together they bring a wealth of experience to Veradigm, to help build upon the company’s vision of transforming health, insightfully. Ms. Rodriguez joins the Veradigm Board with over 30 years of experience in the biopharmaceutical industry, in a broad range of executive leadership roles. She currently serves as Chief Commercial Officer at Ardelyx, Inc., where she has been responsible for leadi..." |
|
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 12.4% stake in Allscripts Healthcare Solutions Inc. |
| 01/26/2023 |
SC 13G/A
| BlackRock Inc. reports a 19.1% stake in ALLSCRIPTS HEALTHCARE SOLUTIONS INC |
| 01/20/2023 |
SC 13G/A
| BlackRock Inc. reports a 19.1% stake in ALLSCRIPTS HEALTHCARE SOLUTIONS INC |
| 01/11/2023 |
8-K
| Investor presentation |
| 12/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|